Chrystal Paulos to T-Lymphocytes
This is a "connection" page, showing publications Chrystal Paulos has written about T-Lymphocytes.
Connection Strength
3.203
-
Fundamentals of T Cell Metabolism and Strategies to Enhance Cancer Immunotherapy. Front Immunol. 2021; 12:645242.
Score: 0.551
-
Novel immunotherapies for hematologic malignancies. Immunol Rev. 2015 Jan; 263(1):90-105.
Score: 0.359
-
Putting the brakes on BTLA in T cell-mediated cancer immunotherapy. J Clin Invest. 2010 Jan; 120(1):76-80.
Score: 0.253
-
Adoptive immunotherapy: good habits instilled at youth have long-term benefits. Immunol Res. 2008; 42(1-3):182-96.
Score: 0.221
-
Toll-like receptors in tumor immunotherapy. Clin Cancer Res. 2007 Sep 15; 13(18 Pt 1):5280-9.
Score: 0.216
-
Stress-Mediated Attenuation of Translation Undermines T-cell Activity in Cancer. Cancer Res. 2022 12 02; 82(23):4386-4399.
Score: 0.155
-
Effective Activation and Expansion of Canine Lymphocytes Using a Novel Nano-Sized Magnetic Beads Approach. Front Immunol. 2021; 12:604066.
Score: 0.137
-
Identification of human CD4+ T cell populations with distinct antitumor activity. Sci Adv. 2020 07; 6(27).
Score: 0.131
-
Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge 2018" (28-29 November, 2018, Naples, Italy). J Immunother Cancer. 2019 11 29; 7(1):332.
Score: 0.126
-
Pro-Survival Lipid Sphingosine-1-Phosphate Metabolically Programs T Cells to Limit Anti-tumor Activity. Cell Rep. 2019 08 13; 28(7):1879-1893.e7.
Score: 0.123
-
Fueling Cancer Immunotherapy With Common Gamma Chain Cytokines. Front Immunol. 2019; 10:263.
Score: 0.119
-
Molecular properties of gp100-reactive T-cell receptors drive the cytokine profile and antitumor efficacy of transgenic host T cells. Pigment Cell Melanoma Res. 2019 01; 32(1):68-78.
Score: 0.115
-
CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response. Cell Metab. 2018 01 09; 27(1):85-100.e8.
Score: 0.109
-
Inducible Enhancement of T Cell Function and Anti-tumor Activity after Adoptive Transfer. Mol Ther. 2017 09 06; 25(9):1995-1996.
Score: 0.108
-
Harnessing the Microbiome to Enhance Cancer Immunotherapy. J Immunol Res. 2015; 2015:368736.
Score: 0.092
-
Identification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T cells. Cancer Immunol Res. 2015 Apr; 3(4):356-67.
Score: 0.090
-
A human memory T cell subset with stem cell-like properties. Nat Med. 2011 Sep 18; 17(10):1290-7.
Score: 0.071
-
Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor. Cancer Res. 2010 Nov 15; 70(22):9053-61.
Score: 0.067
-
Increased intensity lymphodepletion enhances tumor treatment efficacy of adoptively transferred tumor-specific T cells. J Immunother. 2010 Jan; 33(1):1-7.
Score: 0.063
-
Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy). J Immunother Cancer. 2018 07 11; 6(1):69.
Score: 0.029
-
Adoptive Transfer of Ceramide Synthase 6 Deficient Splenocytes Reduces the Development of Colitis. Sci Rep. 2017 Nov 14; 7(1):15552.
Score: 0.027
-
Targeted Complement Inhibition Protects Vascularized Composite Allografts From Acute Graft Injury and Prolongs Graft Survival When Combined With Subtherapeutic Cyclosporine A Therapy. Transplantation. 2017 04; 101(4):e75-e85.
Score: 0.026
-
Interleukin-2-dependent mechanisms of tolerance and immunity in vivo. J Immunol. 2006 May 01; 176(9):5255-66.
Score: 0.012